Loading asset research
Amarin Corporation plc
AMRNNasdaq · USD · StocksQuote as of · Exchange session not verified$13.80
-1.71%
Today
AMRN
Loading 1D prices…
Market cap
$291.5M
Volume
49.4K
52w high
$20.9052w low
$12.96Company profile
Amarin Corporation plc
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Dublin, United States
Employees
80
Fiscal year end
1231
CIK
897448
Session & valuation
Open$14.09
Previous close$14.04
Day high$14.10
Day low$13.68
30-day avg. volume73.6K
Outstanding shares380.7K
Diluted EPS-$0.09
Latest annual period
P/E (trailing)-153.33
P/E (forward)14.08
Price / book0.65
Beta0.76
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| FULCFulcrum Therapeutics Inc. Common Stock | $289.9M | $0.00 | — | -$1.18 | 0.00% | Sell |
| LYELLyell Immunopharma Inc. Common Stock | $293.1M | $36K | -762355.56% | -$16.06 | -1.97% | Buy |
| VCREVicore Pharma Holding AB American Depositary Shares | $303.5M | — | — | -$19.90 | -6.34% | Unrated |
| IMRXImmuneering Corporation Class A Common Stock | $276.3M | $0.00 | — | -$1.27 | -7.00% | Buy |
| VNDAVanda Pharmaceuticals Inc. Common Stock | $307.8M | $216.1M | -102.03% | -$3.74 | +0.99% | Buy |